![Debra P. Gayda](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Debra P. Gayda
General Counsel bei Alita Pharmaceuticals, Inc.
Ursprung des Netzwerks ersten Grades von Debra P. Gayda
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Alita Pharmaceuticals, Inc.
![]() Alita Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alita Pharmaceuticals, Inc. develops, manufactures and distributes urologic and female healthcare products. It offers product testing, research and development services. The company was founded by Carole S. Ben-Maimon and Warburg Pincus in September 2006 and is headquartered in Radnor, PA.
3
| Private Company | Pharmaceuticals: Major | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Debra P. Gayda
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
LIGAND PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Director of Finance/CFO | |
Warburg Pincus LLC
![]() Warburg Pincus LLC Investment ManagersFinance Warburg Pincus LLC (Warburg Pincus) is a private equity subsidiary of Warburg Pincus & Company US LLC founded in 1966. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
HONEYWELL INTERNATIONAL INC. | Aerospace & Defense | Corporate Officer/Principal | |
Allos Therapeutics, Inc.
![]() Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Director/Board Member | |
BARR PHARMACEUTICALS INC | Pharmaceuticals: Generic | Chief Tech/Sci/R&D Officer | |
Transposagen Biopharmaceuticals, Inc.
![]() Transposagen Biopharmaceuticals, Inc. BiotechnologyHealth Technology Transposagen Biopharmaceuticals, Inc. operates as a biotechnology company. Its products and services include piggyBac Reagents, cell engineering services and gene editing reagents & kits. The company was founded by Ostertag M. Eric in 2005 and is headquartered in Lexington, KY. | Biotechnology | Director/Board Member | |
Sprout Group
![]() Sprout Group Investment ManagersFinance Sprout Group (Sprout) is venture capital subsidiary of Credit Suisse Private Equity LLC founded in 1969. The firm headquartered in New York. | Investment Managers | Corporate Officer/Principal | |
McKinsey & Co., Inc.
![]() McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
JOHNSON MATTHEY PLC | Chemicals: Major Diversified | Corporate Officer/Principal | |
University of Pennsylvania | College/University | Undergraduate Degree | |
STADA ARZNEIMITTEL | Pharmaceuticals: Major | President | |
Drexel University | College/University | Graduate Degree Graduate Degree | |
Aton Pharma, Inc.
![]() Aton Pharma, Inc. Pharmaceuticals: MajorHealth Technology Aton Pharma, Inc. develops therapeutics for cancer and other diseases. Its products include Edecrin, Sodium Edecrin, Cuprimine, Demser and Syprine. The company was founded by Michael G. Wells in 2001 and is headquartered in Lawrenceville, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Arcadia University
![]() Arcadia University Other Consumer ServicesConsumer Services GNP is a premier provider of complex systems manufacturing for the embedded control and communications marketplace. The company designs, manufactures and customizes open system platforms to meet the demanding requirements of its customers' programs, using Commercial off-the-shelf (COTS) technology enhanced by system building blocks of its own design | College/University | Undergraduate Degree | |
Talon Therapeutics, Inc.
![]() Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Director/Board Member | |
Temple University (Pennsylvania) | College/University | Doctorate Degree | |
Teva Pharmaceuticals USA, Inc.
![]() Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Merck Research Laboratories Massachusetts LLC
![]() Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Corporate Officer/Principal | |
CONNECT
![]() CONNECT Miscellaneous Commercial ServicesCommercial Services CONNECT creates and scales companies in the technology and life sciences sectors. It creates an environment in which entrepreneurs and C-suite executives have access to the people, capital, and technology resources. The organization was founded in 1985 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
Perelman School of Medicine | College/University | Doctorate Degree | |
Harvard College | College/University | Undergraduate Degree | |
POSEIDA THERAPEUTICS, INC. | Biotechnology | President | |
AFYX Therapeutics AS
![]() AFYX Therapeutics AS Miscellaneous Commercial ServicesCommercial Services AFYX Therapeutics AS engages in research and development of pharmaceutical drugs. It develops a platform designed to deliver a pharmaceutical drug uni-directional to a mucosal surface. The company was founded in May 2014 and is headquartered in Virum, Denmark. | Miscellaneous Commercial Services | Chief Executive Officer | |
Radionetics Oncology, Inc.
![]() Radionetics Oncology, Inc. Pharmaceuticals: MajorHealth Technology Radionetics Oncology, Inc. is a clinical stage radiopharmaceutical company based in Menlo Park, CA. Radionetics Oncology, Inc. focuses on the discovery and development of novel radiotherapeutics for the treatment of various oncology indications. Radionetics Oncology spun out of Crinetics Pharmaceuticals and is supported by Frazier Life Sciences, 5AM Ventures, DCVC Bio, Crinetics Pharmaceuticals, and GordonMD Investments. The company is advancing a pipeline of small molecule radioligands that target G-protein coupled receptors to treat a wide range of cancers, including adrenocortical carcinoma, breast cancer, and lung cancer. The company's platform technology uses nonpeptide, small molecule targeting to deliver therapeutic radioisotopes selectively to tumors expressing peptide receptors. The company's pipeline consists of multiple lead drug candidates, and they are conducting additional drug discovery efforts in collaboration with Crinetics Pharmaceuticals. The market for radiopharmaceuticals is expected to rise to $12.6 billion by 2027. The company was founded by Scott R. Struthers, and Paul A. Grayson has been the CEO since 2024. | Pharmaceuticals: Major | Chief Executive Officer |
Statistik
International
Vereinigte Staaten | 25 |
Deutschland | 3 |
Kanada | 2 |
Bermuda | 2 |
Vereinigtes Königreich | 2 |
Sektoral
Health Technology | 14 |
Consumer Services | 8 |
Process Industries | 4 |
Commercial Services | 4 |
Electronic Technology | 3 |
Operativ
Corporate Officer/Principal | 13 |
Director/Board Member | 11 |
Undergraduate Degree | 3 |
Independent Dir/Board Member | 3 |
Chief Executive Officer | 2 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Nishan de Silva | 18 |
Wayne S. Mulcahy | 9 |
Paul Evans | 8 |
- Börse
- Insiders
- Debra P. Gayda
- Unternehmensverbindungen